Impact of post-challenge hyperglycemia on clinical outcomes in japanese patients with stable angina undergoing percutaneous coronary intervention

Table 3 Cumulative incidence of clinical events during the follow-up period

	DM (n=452)	PH (n=236)	NGT (n=140)	P value
MACE	178 (39.3)*†	74 (31.4)†	29 (20.7)	<0.001
All-cause Death	37 (8.1)*†	8 (3.3)	3 (2.1)	0.006
Non-cardiovascular	21 (4.6)	4 (1.6)	3 (2.1)	0.08
Cardiovascular	16 (3.5)	4 (1.6)	0 (0.0)	0.041
Stroke	20 (4.4)	8 (3.3)	3 (2.1)	0.5
MI	12 (2.6)	6 (2.5)	2 (1.4)	0.7
Revascularization	159 (35.1)*†	64 (27.1)	26 (18.5)	<0.001
PCI	157 (34.7)*†	63 (26.6)	26 (18.5)	<0.001
TLR	47 (10.3)†	13 (5.5)	4 (2.8)	0.005
TVR	80 (17.6)*†	27 (11.4)	10 (7.1)	0.002
Non-TVR	101 (22.3)	42 (17.8)	19 (13.5)	0.055
CABG	12 (2.6)	3 (1.2)	0 (0.0)	0.09

Values are expressed as number and percentage. *P <0.05 vs. PH; †P <0.05 vs. NGT. TLR, target lesion revascularization; TVR, target vessel revascularization. Other abbreviations as in Table 1.

ISSN: 1475-2840